开放之门越开越大，拜耳中国用144年投出在华信任票

Core Viewpoint - The article emphasizes Bayer's long-term commitment to the Chinese market, highlighting its strategic investments and innovations that align with China's economic policies and development goals [1][2][3]. Group 1: Bayer's Historical Commitment to China - Bayer has been rooted in China for 144 years, marking its presence as one of the earliest multinational companies in the country [2]. - The establishment of Bayer China Limited in 1994 signified a systematic and comprehensive approach to its operations in China, evolving from trade to a full ecosystem of manufacturing, research, and innovation [2]. - Over the past three decades, Bayer has continuously increased its investment in China, including modern pharmaceutical production facilities and research centers [3]. Group 2: Recent Developments and Investments - In 2024, Bayer will launch two major research and innovation platforms in Shanghai, and by 2025, it will open a manufacturing center for crop protection products in Hangzhou with an investment exceeding 300 million RMB [3]. - As of March 2026, Bayer is expected to employ around 7,000 people in China and has established multiple supply and research centers [3]. Group 3: Alignment with Chinese Policies - Bayer's mission of "shared health and eliminating hunger" aligns with China's emphasis on biomedicine as a new pillar industry and its initiatives for rural revitalization and agricultural modernization [6][8]. - The company has successfully launched 19 innovative prescription drugs in China, reflecting its ability to synchronize with the country's drug approval processes [6]. Group 4: Innovation and Collaboration - Bayer is transitioning from merely introducing global innovations to enabling Chinese innovations to reach the world, exemplified by its partnerships with top Chinese universities and local biotech firms [11][12]. - The Bayer Co.Lab in China supports startups by providing funding, technical empowerment, and global networking opportunities, facilitating their entry into international markets [12]. Group 5: Future Outlook - Bayer aims to continue collaborating with Chinese innovation partners to build a community that benefits both China and the global market, contributing to sustainable development and national strategic goals [12].